SCHEMBL2094052

SCHEMBL2094052

CC(NCC#N)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
HPGD P15428 1/20 0.47
MAPT P10636 2/20 0.42
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
CYP1A2 P05177 2/20 0.42
TSHR P16473 2/20 0.42
HSD17B10 Q99714 1/20 0.40
SGMS2 Q8NHU3 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
POLB P06746 2/20 0.38
GAA P10253 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL335672 0.79 KAT2B (0.47) ALDH1A1MAPTCYP1A2TSHRHSD17B10
SCHEMBL22204495 0.78 ALDH1A1 (0.50) ALDH1A1HPGDMAPTCDK5CDK5R1
SCHEMBL28496382 0.77 RAB9A (0.49) ALDH1A1MAPTCYP1A2TSHRSMN1; SMN2
SCHEMBL15492564 0.76 ALDH1A1 (0.47) ALDH1A1HPGDMAPTCDK5CDK5R1
SCHEMBL9051742 0.76 ALDH1A1 (0.50) ALDH1A1HPGDMAPTCDK5CDK5R1
SCHEMBL3756135 0.76 ALDH1A1 (0.53) ALDH1A1MAPTCYP1A2TSHRHSD17B10
SCHEMBL30937671 0.75 ALDH1A1 (0.57) ALDH1A1MAPTCYP1A2TSHRSMN1; SMN2
SCHEMBL27496185 0.73 ALDH1A1 (0.53) ALDH1A1MAPTCDK5CDK5R1CYP1A2
SCHEMBL5799452 0.73 ALDH1A1 (0.58) ALDH1A1MAPTCYP1A2TSHRHSD17B10
SCHEMBL16284318 0.73 ALDH1A1 (0.56) ALDH1A1MAPTCYP1A2TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8673898-B2 Aminodiazepines as toll-like receptor modulators ARRAY BIOPHARMA INC. (US) 2014-03-18 US disclosed
US-8673898-B2 Aminodiazepines as toll-like receptor modulators ARRAY BIOPHARMA INC. (US) 2014-03-18 US disclosed
US-8673898-B2 Aminodiazepines as toll-like receptor modulators ARRAY BIOPHARMA INC. (US) 2014-03-18 US disclosed
EP-1928845-B1 Aminodiazepines as toll-like receptor modulators ARRAY BIOPHARMA INC (US) 2013-07-10 EP disclosed
EP-1928845-B1 Aminodiazepines as toll-like receptor modulators ARRAY BIOPHARMA INC (US) 2013-07-10 EP disclosed
US-20120208801-A1 Aminodiazepines as Toll-Like Receptor Modulators ARRAY BIOPHARMA INC. (US) 2012-08-16 US disclosed
US-20120208801-A1 Aminodiazepines as Toll-Like Receptor Modulators ARRAY BIOPHARMA INC. (US) 2012-08-16 US disclosed
US-8163738-B2 Aminodiazepines as toll-like receptor modulators ARRAY BIOPHARMA INC. (US) 2012-04-24 US disclosed
US-8163738-B2 Aminodiazepines as toll-like receptor modulators ARRAY BIOPHARMA INC. (US) 2012-04-24 US disclosed
US-8163738-B2 Aminodiazepines as toll-like receptor modulators ARRAY BIOPHARMA INC. (US) 2012-04-24 US disclosed
US-20080306050-A1 Aminodiazepines as Toll-Like Receptor Modulators ARRAY BIOPHARMA INC. (CO) 2008-12-11 US disclosed
CN-101287716-A Aminodiazepine * as TOLL-like receptor modulators ARRAY BIOPHARMA INC (US) 2008-10-15 CN disclosed
WO-2007040840-A2 AMINODIAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS ARRAY BIOPHARMA INC. (US) 2007-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208801-A1 Aminodiazepines as Toll-Like Receptor Modulators TLR8, TLR1, TLR5 ALDH1A1 3557/4885HPGD 3380/4885MAPT 2744/4885
US-20080306050-A1 Aminodiazepines as Toll-Like Receptor Modulators TLR8, TLR1, TLR5 ALDH1A1 3557/4885HPGD 3380/4885MAPT 2744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.